Long Bai

1.1k total citations
31 papers, 876 citations indexed

About

Long Bai is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Long Bai has authored 31 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Long Bai's work include Gastric Cancer Management and Outcomes (10 papers), Colorectal Cancer Treatments and Studies (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Long Bai is often cited by papers focused on Gastric Cancer Management and Outcomes (10 papers), Colorectal Cancer Treatments and Studies (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Long Bai collaborates with scholars based in China, United States and Belgium. Long Bai's co-authors include Rui‐Hua Xu, De‐Shen Wang, Dong-sheng Zhang, Miao‐Zhen Qiu, Chao Ren, Hui Luo, Ying Jin, Feng‐Hua Wang, Feng Wang and Zhao-Lei Zeng and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Long Bai

29 papers receiving 869 citations

Peers

Long Bai
Luai H. Ashari Saudi Arabia
Zhenhai Lu China
Chen Huang China
Alaa Abduljabbar Saudi Arabia
Cheng–Lung Hsu Taiwan
Javier Molina‐Cerrillo Spain
Zhao‐Ru Dong China
Kien Thiam Tan Taiwan
Luai H. Ashari Saudi Arabia
Long Bai
Citations per year, relative to Long Bai Long Bai (= 1×) peers Luai H. Ashari

Countries citing papers authored by Long Bai

Since Specialization
Citations

This map shows the geographic impact of Long Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long Bai more than expected).

Fields of papers citing papers by Long Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Long Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long Bai. The network helps show where Long Bai may publish in the future.

Co-authorship network of co-authors of Long Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Long Bai. A scholar is included among the top collaborators of Long Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Long Bai. Long Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Long, et al.. (2023). A follow-up study of 100 patients with acute brucellosis for its prognosis and prevention. Frontiers in Medicine. 10. 1110907–1110907. 2 indexed citations
2.
Lu, Yun‐Xin, Qi Meng, Long Bai, et al.. (2022). LINC00858 stabilizes RAN expression and promotes metastasis of gastric cancer. Biology Direct. 17(1). 41–41. 8 indexed citations
3.
Bai, Long, Xiaoluan Yan, Yun‐Xin Lu, et al.. (2022). Circulating Lipid- and Inflammation-Based Risk (CLIR) Score: A Promising New Model for Predicting Outcomes in Complete Colorectal Liver Metastases Resection. Annals of Surgical Oncology. 29(7). 4308–4323. 4 indexed citations
4.
Li, Lin, Long Bai, Huan Lin, et al.. (2021). Multiomics analysis of tumor mutational burden across cancer types. Computational and Structural Biotechnology Journal. 19. 5637–5646. 19 indexed citations
5.
Ruan, Dan‐Yun, Ting Li, Yingnan Wang, et al.. (2021). FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis. Oncogene. 40(33). 5168–5181. 116 indexed citations
6.
Ren, Chao, Long Bai, Jie‐Ying Liang, et al.. (2021). Efficacy and safety of modified FOLFIRINOX as salvage therapy for patients with refractory advanced biliary tract cancer: a retrospective study. Investigational New Drugs. 39(3). 836–845. 11 indexed citations
7.
8.
Liu, Shousheng, Chang Jiang, Lin Yang, et al.. (2020). First-line cetuximab improves the efficacy of subsequent bevacizumab for RAS wild-type left-sided metastatic colorectal cancer: an observational retrospective study. Scientific Reports. 10(1). 12336–12336. 8 indexed citations
9.
Guo, Guifang, Xiuxing Chen, Xiuyu Cai, et al.. (2019). Inflammation-based markers can predict the prognosis of geriatric patients with metastatic colorectal cancer receiving first-line chemotherapy. Translational Cancer Research. 8(4). 1137–1147. 9 indexed citations
10.
Bai, Long, Feng Wang, Chao Ren, et al.. (2016). Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer. Medicine. 95(51). e4531–e4531. 13 indexed citations
11.
Bai, Long, Feng Wang, Fang Wang, et al.. (2016). Comparison of KRAS mutation status between primary tumor and metastasis in Chinese colorectal cancer patients. Medical Oncology. 33(7). 71–71. 14 indexed citations
12.
Lu, Yun-Xin, Dong-liang Chen, De‐Shen Wang, et al.. (2016). Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathway. Cell Death and Disease. 7(10). e2432–e2432. 51 indexed citations
13.
Wang, Feng, Long Bai, Ming-Ming He, et al.. (2015). Right- and left-sided colorectal cancers respond differently to cetuximab. Chinese Journal of Cancer. 34(3). 384–93. 57 indexed citations
14.
Wei, Xiaoli, Feng‐Hua Wang, Dongsheng Zhang, et al.. (2015). A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio. BMC Cancer. 15(1). 350–350. 140 indexed citations
15.
Bai, Long, Dong-sheng Zhang, Wen-jing Wu, et al.. (2015). Clinical outcomes of Chinese patients with metastatic colorectal cancer receiving first-line bevacizumab-containing treatment. Medical Oncology. 32(2). 469–469. 9 indexed citations
16.
Wei, Xiao-Li, Dong-sheng Zhang, Ming-Ming He, et al.. (2015). The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinoma. Tumor Biology. 37(2). 1879–1887. 36 indexed citations
17.
18.
Xu, Rui‐Hua, Feng Wang, Feng‐Hua Wang, & Long Bai. (2014). Role of capecitabine in treating metastatic colorectal cancer in Chinese patients. OncoTargets and Therapy. 7. 501–501. 9 indexed citations
19.
Qiu, Miao‐Zhen, Qian Li, Zhiqiang Wang, et al.. (2013). HER2-positive patients receiving trastuzumab treatment have a comparable prognosis with HER2-negative advanced gastric cancer patients: A prospective cohort observation. International Journal of Cancer. 134(10). 2468–2477. 52 indexed citations
20.
Jin, Ying, Miao‐Zhen Qiu, De‐Shen Wang, et al.. (2013). Adjuvant Chemotherapy for Elderly Patients with Gastric Cancer after D2 Gastrectomy. PLoS ONE. 8(1). e53149–e53149. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luai H. Ashari Breakdown of academic impact, for papers by Zhenhai Lu Breakdown of academic impact, for papers by Chen Huang Breakdown of academic impact, for papers by Alaa Abduljabbar Breakdown of academic impact, for papers by Cheng–Lung Hsu Breakdown of academic impact, for papers by Javier Molina‐Cerrillo Breakdown of academic impact, for papers by Zhao‐Ru Dong Breakdown of academic impact, for papers by Kien Thiam Tan
Rankless by CCL
2026